Posted in | News | Medical Robotics

Accuray Signs Radiation Oncology Research Collaboration Agreement with Erasmus

Accuray has recently declared that it has signed a multi-year master research and collaboration agreement with Rotterdam, a Netherlands-based Erasmus Medical Center (MC). Through this partnership on advanced research in radiation oncology, Accuray and Erasmus MC will promote treatment technology and innovative medical tools that will enable healthcare experts to provide better treatment.

Since the 2004 installation of its first CyberKnife Robotic Radiosurgery System, Accuray has been working with Erasmus MC on research initiatives, enabling Erasmus to be the fourth site in the Europe India Middle East and Africa (EIMEA) region to have its centre installed with CyberKnife System. So far, Erasmus MC has used CyberKnife System to treat over 1,000 patients. Additionally, Erasmus conducted a clinical research on the extensive application of the CyberKnife System. It has served as author for several book chapters and over 20 technical and clinical publications in peer-reviewed journals. Based on innovative research methods, the center has carried out evaluation on the CyberKnife System’s performance, such as dose calculation accuracy assessments, assessment of the impact of intra-fraction patient motion on clinical tracking accuracy, Synchrony Respiratory Tracking System-based clinical tracking accuracy of lung treatments, and methods for minimal treatment time. At present, the center is assessing hypothetical path sets and also evaluates the InTempo Adaptive Imaging System that improves the CyberKnife System’s capability in consistent tracking and rectifying of prostate movement during treatment.

During the last quarter, Accuray reported two additional research and collaboration agreements with two Heidelberg-based luminary research institutions, including the German Cancer Research Center, and the University of Heidelberg.

Source: http://www.accuray.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Accuray Incorporated. (2019, February 20). Accuray Signs Radiation Oncology Research Collaboration Agreement with Erasmus. AZoRobotics. Retrieved on May 05, 2024 from https://www.azorobotics.com/News.aspx?newsID=2934.

  • MLA

    Accuray Incorporated. "Accuray Signs Radiation Oncology Research Collaboration Agreement with Erasmus". AZoRobotics. 05 May 2024. <https://www.azorobotics.com/News.aspx?newsID=2934>.

  • Chicago

    Accuray Incorporated. "Accuray Signs Radiation Oncology Research Collaboration Agreement with Erasmus". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=2934. (accessed May 05, 2024).

  • Harvard

    Accuray Incorporated. 2019. Accuray Signs Radiation Oncology Research Collaboration Agreement with Erasmus. AZoRobotics, viewed 05 May 2024, https://www.azorobotics.com/News.aspx?newsID=2934.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.